• Company
• Exclusive domestic sales of JW Shinyak, Galderma hair loss
• by Mar 16, 2023 05:45am

• InterView
• ‘Reimbursing Revlimid as maintenance therapy beneficial’
• by Eo, Yun-Ho Mar 16, 2023 05:45am

• Company
• SPC Korea to exclusively distribute 2 new COPD drugs in KOR
• by Eo, Yun-Ho Mar 16, 2023 05:45am

• Policy
• Upper limit re-evaluation of drugs in the negotiation stage
• by Lee, Tak-Sun Mar 16, 2023 05:45am

• Policy
• MFDS, approval of Vadadustat for anemia tx of renal disease
• by Lee, Hye-Kyung Mar 15, 2023 05:56am

• Company
• IIT seeks use of Leclaza in the first line in Korea
• by Jin-Joong Hwang Mar 15, 2023 05:56am

• Opinion
• [Reporter’s View] ‘The smart office system’s great, but…
• by Eo, Yun-Ho Mar 15, 2023 05:56am

• Company
• Pfizer pays an average of 1.1 billion won per person
• by Jung, Sae-Im Mar 15, 2023 05:56am

• Policy
• MOHW provides real-time confirmation service
• by Lee, Jeong-Hwan Mar 15, 2023 05:56am

• Company
• HPV vaccination for males a necessity rather than an option
• by Whang, byung-woo Mar 14, 2023 05:51am